Literature DB >> 16774804

Assessing bleeding in von Willebrand disease with bleeding score.

Alberto Tosetto1, Giancarlo Castaman, Francesco Rodeghiero.   

Abstract

Quantification of the bleeding severity in von Willebrand disease (VWD) by use of a bleeding score (BS) could be a useful tool toward a more objective diagnosis. The BS is computed as the sum of arbitrary grades of bleeding severity for several hemorrhagic symptoms, and in normal subjects is nearly always lower than 3. In the diagnosis of type 1 VWD, the use of the BS provided a high specificity (99.1%) and a satisfactory sensitivity (64.2%) in a multicenter, retrospective study. The BS is strongly related to all available measurements of von Willebrand factor activity, including the PFA-100 closure time. The BS could be used to assess the influence on bleeding symptoms of other biological factors in VWD. Therefore, BS represent a promising clinical tool for the analysis of bleeding in VWD, although further validation is warranted before an extensive use in clinical practice could be purported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774804     DOI: 10.1016/j.blre.2006.04.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  8 in total

1.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors:  V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Authors:  Karen Freitas Santos; Vanessa Battisti; Maísa de Carvalho Corrêa; Thaís Rapachi Mann; Renata da Silva Pereira; Maria do Carmo Araújo; Alice Odete Brülê; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Mol Cell Biochem       Date:  2010-03-25       Impact factor: 3.396

3.  Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Authors:  Michelle Lavin; Sonia Aguila; Sonja Schneppenheim; Niall Dalton; Kenneth L Jones; Jamie M O'Sullivan; Niamh M O'Connell; Kevin Ryan; Barry White; Mary Byrne; Marie Rafferty; Mairead M Doyle; Margaret Nolan; Roger J S Preston; Ulrich Budde; Paula James; Jorge Di Paola; James S O'Donnell
Journal:  Blood       Date:  2017-09-15       Impact factor: 22.113

4.  Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children.

Authors:  N Mittal; R Naridze; P James; S Shott; L A Valentino
Journal:  Haemophilia       Date:  2015-05-16       Impact factor: 4.287

5.  A simplified flow cytometric method for detection of inherited platelet disorders-A comparison to the gold standard light transmission aggregometry.

Authors:  Kristoffer Navred; Myriam Martin; Lina Ekdahl; Eva Zetterberg; Nadine Gretenkort Andersson; Karin Strandberg; Eva Norstrom
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

6.  Inflammatory Biomarkers in Postural Orthostatic Tachycardia Syndrome with Elevated G-Protein-Coupled Receptor Autoantibodies.

Authors:  William T Gunning; Stanislaw M Stepkowski; Paula M Kramer; Beverly L Karabin; Blair P Grubb
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

7.  Platelet Aggregation Assays Do Not Reliably Diagnose Platelet Delta Granule Storage Pool Deficiency.

Authors:  William T Gunning; Lorene Yoxtheimer; Mary R Smith
Journal:  J Hematol       Date:  2021-07-28

8.  Diagnostic work up of patients with increased bleeding tendency.

Authors:  Suzanne A M Zegers; Yolba Smit; Joline L Saes; Clint van Duren; Tim J Schuijt; Waander L van Heerde; Saskia E M Schols
Journal:  Haemophilia       Date:  2019-12-30       Impact factor: 4.287

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.